Capital Nasdaq (Taiwan) Probability of Future Etf Price Finishing Under 24.82

00678 Etf  TWD 28.74  0.64  2.18%   
Capital Nasdaq's future price is the expected price of Capital Nasdaq instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Capital Nasdaq Biotechnology performance during a given time horizon utilizing its historical volatility. Check out Capital Nasdaq Backtesting, Portfolio Optimization, Capital Nasdaq Correlation, Capital Nasdaq Hype Analysis, Capital Nasdaq Volatility, Capital Nasdaq History as well as Capital Nasdaq Performance.
  
Please specify Capital Nasdaq's target price for which you would like Capital Nasdaq odds to be computed.

Capital Nasdaq Target Price Odds to finish below 24.82

The tendency of Capital Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to NT$ 24.82  or more in 90 days
 28.74 90 days 24.82 
near 1
Based on a normal probability distribution, the odds of Capital Nasdaq to drop to NT$ 24.82  or more in 90 days from now is near 1 (This Capital Nasdaq Biotechnology probability density function shows the probability of Capital Etf to fall within a particular range of prices over 90 days) . Probability of Capital Nasdaq Biote price to stay between NT$ 24.82  and its current price of NT$28.74 at the end of the 90-day period is nearly 4.45 .
Assuming the 90 days trading horizon Capital Nasdaq has a beta of 0.51. This suggests as returns on the market go up, Capital Nasdaq average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Capital Nasdaq Biotechnology will be expected to be much smaller as well. Additionally Capital Nasdaq Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Capital Nasdaq Price Density   
       Price  

Predictive Modules for Capital Nasdaq

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Capital Nasdaq Biote. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
27.6428.7429.84
Details
Intrinsic
Valuation
LowRealHigh
27.8728.9730.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Capital Nasdaq. Your research has to be compared to or analyzed against Capital Nasdaq's peers to derive any actionable benefits. When done correctly, Capital Nasdaq's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Capital Nasdaq Biote.

Capital Nasdaq Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Capital Nasdaq is not an exception. The market had few large corrections towards the Capital Nasdaq's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Capital Nasdaq Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Capital Nasdaq within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.14
β
Beta against Dow Jones0.51
σ
Overall volatility
0.70
Ir
Information ratio -0.17

Capital Nasdaq Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Capital Nasdaq for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Capital Nasdaq Biote can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Capital Nasdaq Biote generated a negative expected return over the last 90 days
The fund holds 98.58% of its total net assets in equities

Capital Nasdaq Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Capital Etf often depends not only on the future outlook of the current and potential Capital Nasdaq's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Capital Nasdaq's indicators that are reflective of the short sentiment are summarized in the table below.
Average Daily Volume Last 10 Day492.66k
Average Daily Volume In Three Month427.16k

Capital Nasdaq Technical Analysis

Capital Nasdaq's future price can be derived by breaking down and analyzing its technical indicators over time. Capital Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Capital Nasdaq Biotechnology. In general, you should focus on analyzing Capital Etf price patterns and their correlations with different microeconomic environments and drivers.

Capital Nasdaq Predictive Forecast Models

Capital Nasdaq's time-series forecasting models is one of many Capital Nasdaq's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Capital Nasdaq's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.

Things to note about Capital Nasdaq Biote

Checking the ongoing alerts about Capital Nasdaq for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Capital Nasdaq Biote help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Capital Nasdaq Biote generated a negative expected return over the last 90 days
The fund holds 98.58% of its total net assets in equities

Other Information on Investing in Capital Etf

Capital Nasdaq financial ratios help investors to determine whether Capital Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Capital with respect to the benefits of owning Capital Nasdaq security.